CANBRIDGE PHARM.DL-00001 (MF1) — Cash Flow Quality Index

Latest as of December 2025: -2.58x

CANBRIDGE PHARM.DL-00001 (MF1) has a Cash Flow Quality Index of -2.58x as of December 2025. Operating cash flow of €-38.21 Million is below net income of €14.82 Million, suggesting accrual-heavy earnings not yet converted to cash. Also explore how large is CANBRIDGE PHARM.DL-00001's balance sheet for the complete picture of this company's asset base.

Cash Flow Quality Index

-2.58x
Operating CF / Net Income

Operating Cash Flow

€-38.21 Million
EUR

Net Income

€14.82 Million
EUR

Data as of

Dec 2025
Most recent filing

CANBRIDGE PHARM.DL-00001 Cash Flow Quality Index (2025–2025)

Historical Cash Flow Quality Index for CANBRIDGE PHARM.DL-00001 across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check tangible equity quality of CANBRIDGE PHARM.DL-00001 to evaluate the tangible quality of the company's equity base.

Annual Cash Flow Quality Index for CANBRIDGE PHARM.DL-00001 (2025–2025)

Year-by-year earnings quality comparison for CANBRIDGE PHARM.DL-00001. For live market cap and the full company financial profile, see MF1 market cap overview.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2025 -2.58x €-38.21 Million €14.82 Million
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.